Meena B. Bansal
- Hepatology top 0.5%
- Liver physiology and pathology 15
- Hepatitis C virus research 11
- Liver Disease and Transplantation 10
- Liver Diseases and Immunity 8
- Epidemiology top 1%
- Liver Disease Diagnosis and Treatment 42
- Hepatitis B Virus Studies 14
-
- Diet, Metabolism, and Disease 6
- Virology top 5%
- Immunology top 10%
-
- Pancreatitis Pathology and Treatment 5
- Co-authors
- Scott L. FriedmanRebecca TaubMaria Isabel FielNaim AlkhouriStephen A. HarrisonYedidya SaimanMustafa R. BashirCynthia D. Guy
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Meena B. Bansal
62 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Hepatology 1.2k
- Epidemiology 1.6k
- Endocrinology, Diabetes and Metabolism 494
- Virology 92
- Immunology 244
Countries citing papers authored by Meena B. Bansal
This map shows the geographic impact of Meena B. Bansal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meena B. Bansal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meena B. Bansal more than expected).
Fields of papers citing papers by Meena B. Bansal
This network shows the impact of papers produced by Meena B. Bansal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meena B. Bansal. The network helps show where Meena B. Bansal may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Meena B. Bansal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 3 | |
| 4 | 2025 | 3 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 10 | |
| 7 | Expert Panel Recommendations: Practical Clinical Applications for Initiating and Monitoring Resmetirom in Patients With MASH/NASH and Moderate to Noncirrhotic Advanced Fibrosisbreakdown → | 2024 | 55 |
| 8 | Resmetirom: An Orally Administered, Small-molecule, Liver-directed, β-selective THR Agonist for the Treatment of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitisbreakdown → | 2023 | 82 |
| 9 | 2023 | 56 | |
| 10 | 2023 | 23 | |
| 11 | 2023 | 1 | |
| 12 | 2020 | 1 | |
| 13 | 2020 | 41 | |
| 14 | 2018 | 32 | |
| 15 | 2015 | 5 | |
| 16 | 2010 | 166 | |
| 17 | 2005 | 94 | |
| 18 | 2004 | 186 | |
| 19 | 2001 | 39 | |
| 20 | 1989 | 4 |
About Meena B. Bansal
Meena B. Bansal is a scholar working on Hepatology, Epidemiology and Virology, having authored 73 papers that have together received 2.5k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (42 papers), Liver physiology and pathology (15 papers), Hepatitis B Virus Studies (14 papers), Hepatitis C virus research (11 papers), Liver Disease and Transplantation (10 papers), Liver Diseases and Immunity (8 papers), Diet, Metabolism, and Disease (6 papers) and Pancreatitis Pathology and Treatment (5 papers). The work is most often cited by research in Hepatology (1.2k citations), Epidemiology (1.6k citations) and Endocrinology, Diabetes and Metabolism (494 citations). Meena B. Bansal has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Scott L. Friedman, Rebecca Taub, Maria Isabel Fiel, Naim Alkhouri, Stephen A. Harrison, Yedidya Saiman, Mustafa R. Bashir, Cynthia D. Guy, Brent A. Neuschwander‐Tetri and Juan P. Frías. Their work appears in journals such as The Lancet, Nucleic Acids Research and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.